JP2013071928A5 - - Google Patents

Download PDF

Info

Publication number
JP2013071928A5
JP2013071928A5 JP2011213795A JP2011213795A JP2013071928A5 JP 2013071928 A5 JP2013071928 A5 JP 2013071928A5 JP 2011213795 A JP2011213795 A JP 2011213795A JP 2011213795 A JP2011213795 A JP 2011213795A JP 2013071928 A5 JP2013071928 A5 JP 2013071928A5
Authority
JP
Japan
Prior art keywords
cranial nerve
nerve disease
composition
aurapten
heptamethoxyflavone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011213795A
Other languages
English (en)
Japanese (ja)
Other versions
JP5945861B2 (ja
JP2013071928A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011213795A priority Critical patent/JP5945861B2/ja
Priority claimed from JP2011213795A external-priority patent/JP5945861B2/ja
Publication of JP2013071928A publication Critical patent/JP2013071928A/ja
Publication of JP2013071928A5 publication Critical patent/JP2013071928A5/ja
Application granted granted Critical
Publication of JP5945861B2 publication Critical patent/JP5945861B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011213795A 2011-09-29 2011-09-29 医薬組成物及びその製造方法 Active JP5945861B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011213795A JP5945861B2 (ja) 2011-09-29 2011-09-29 医薬組成物及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011213795A JP5945861B2 (ja) 2011-09-29 2011-09-29 医薬組成物及びその製造方法

Publications (3)

Publication Number Publication Date
JP2013071928A JP2013071928A (ja) 2013-04-22
JP2013071928A5 true JP2013071928A5 (enrdf_load_stackoverflow) 2014-12-04
JP5945861B2 JP5945861B2 (ja) 2016-07-05

Family

ID=48476698

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011213795A Active JP5945861B2 (ja) 2011-09-29 2011-09-29 医薬組成物及びその製造方法

Country Status (1)

Country Link
JP (1) JP5945861B2 (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103405649B (zh) * 2013-08-19 2015-05-20 刘建贞 一种用于腓总神经损伤后康复的外用药物组合物
JP6994191B2 (ja) * 2017-08-10 2022-01-14 愛媛県 河内晩柑果皮入り飲食品
JP7457978B2 (ja) * 2019-03-28 2024-03-29 愛媛県 柑橘果皮中の機能性成分濃縮及び保持方法
JP7696201B2 (ja) * 2020-07-29 2025-06-20 国立大学法人愛媛大学 外用又は内用組成物
KR102691281B1 (ko) * 2021-09-14 2024-08-05 충남대학교 산학협력단 아우랍텐 및 탄시논 혼합물을 유효성분으로 함유하는 인지기능, 기억력 및 활동성 증진용 조성물
JP7432195B1 (ja) 2023-01-06 2024-02-16 株式会社和環 オーラプテン含有組成物及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3571899B2 (ja) * 1997-12-18 2004-09-29 小川香料株式会社 香味劣化抑制剤
JP4633897B2 (ja) * 2000-08-17 2011-02-16 長瀬産業株式会社 神経突起伸長剤
JP2004210682A (ja) * 2002-12-27 2004-07-29 Ehime Prefecture カンキツ機能性成分高含有組成物の製造方法
EP1802298B1 (en) * 2004-10-22 2008-12-31 DSMIP Assets B.V. Novel agents for preventing and treating disorders connected to impaired neurotransmission
JP2007332118A (ja) * 2006-06-19 2007-12-27 Minamide Shoji Kk 神経保護剤
JP2008156297A (ja) * 2006-12-25 2008-07-10 Hokkaido Univ セロトニン２ｂおよび／または２ｃ受容体拮抗剤
CN101461803B (zh) * 2007-12-22 2012-01-25 江西中医学院 葡萄内酯的用途

Similar Documents

Publication Publication Date Title
CL2014003475A1 (es) Forma c cristalina de acido obeticolico; proceso de preparacion de la forma 1 de acido obeticolico a partir de la forma c cristalina; composicion farmaceutica que comprende a una forma cristalina de acido obeticolico, util para el tratamiento o prevencion de una enfermedad hepatica colestasica, hepatopatia alcoholica y enfermedades cardiovasculares tal como aterosclerosis, entre otras.
WO2014144100A3 (en) Sgc stimulators
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
MX377600B (es) Estimuladores de sgc.
MX2013006113A (es) Compuestos biciclico.
CL2013001428A1 (es) Compuesto que inhibe la actividad del virus de la hepatitis c (hcv); composición farmacéutica que comprende el compuesto; método de tratamiento de hepatitis c.
IN2014KN00948A (enrdf_load_stackoverflow)
BR112013018898A2 (pt) tratamento dos transtornos do espectro do autismo empregando ácido glicil-l-2-metilprolil-l-glutâmico.
IL230635A (en) An outgrowth of 4,3,2,1-tetrahydroquinoline used to treat diabetes
WO2013120022A3 (en) Treatment of hypoglycemia
LT2914255T (lt) Širdies ir kraujagyslių sistemos sutrikimų gydymas arba prevencija, skiriant kolchiciną
JP2015504870A5 (enrdf_load_stackoverflow)
BR112014004590A2 (pt) processo para efetuar uma oxidação em um suprimento passível de aspersão; e processo para fazer ácido 2,5-furanodicarboxílico a partir de frutose, glicose ou uma combinação de frutos e glicose
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
JP2013071928A5 (enrdf_load_stackoverflow)
BR112014026149A2 (pt) método para a preparação de 2,4-ácido dihidroxibutírico (2,4-dhb) e microrganismo.
HK1225382A1 (zh) 噠嗪酮化合物及其用途
PE20150284A1 (es) Derivado de indanosulfamida novedoso
BRPI1009783A2 (pt) compostos para o tratamento de distúrbios metabólicos.
WO2015120372A3 (en) Compositions and methods to inhibit ezh2 for the treatment of cardiovascular diseases
EP3231436A4 (en) Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient
WO2011127048A3 (en) NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
LT2782602T (lt) Nukleotidas dims0-150, skirtas lėtinio aktyvaus opinio kolito gydymui
MX2017006709A (es) Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.
SI2819516T1 (sl) Uporaba (1R,5S)-(+)-1-(naftalen-2-IL)-3-azabiciklo(3.1.0)heksana pri zdravljenju stanj na katere vplivajo monoamin nevrotransmiterji